UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 189

of 'Overview of neurologic complications of non-platinum cancer chemotherapy'

189
TI
Reversible posterior encephalopathy syndrome associated with bortezomib.
AU
Terwiel E, Hanrahan R, Lueck C, D'Rozario J
SO
Intern Med J. 2010 Jan;40(1):69-71.
 
Reversible posterior encephalopathy (RPES) is an uncommon neurological syndrome that is being increasingly reported in association with anti-neoplastic therapies. The first case of reversible posterior encephalopathy associated with the proteosome inhibitor bortezomib is described and the reported experience of the occurrence of RPES with other antineoplastic therapies reviewed. Dysregulation of cerebral vasomotor autoregulation is postulated as the underlying pathophysiology in this case of bortezomib associated RPES.
AD
Department of Haematology, The Canberra Hospital, Woden, Australian Capital Territory, Australia.
PMID